| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Division of Respiratory and Critical Care Physiology and Medicine, St. John's Cardiovascular Research Center, Harbor-UCLA Medical Center, Torrance, Calif.
2 From the Division of Cardiology, St. John's Cardiovascular Research Center, Harbor-UCLA Medical Center, Torrance, Calif.
Study objectives: Nitric oxide (NO), a potent vasodilator, is present in the exhaled air of humans. We wished to quantify NO production in patients with abnormalities of the pulmonary circulation.
Participants: Nine patients with primary pulmonary hypertension (PPH), six with pulmonary fibrosis (PF), and 20 normal volunteers were studied.
Interventions: All subjects were studied at rest and during continuous incremental (ramp) cycle ergometry exercise. All patients with PPH and nine matched normal volunteers also performed constant exercise at equal absolute work rates.
Measurements and results: The concentration of NO was measured continuously in mixed expired air, and the rate of NO production (VNO) calculated. Peak exercise capacity was markedly impaired in both patient groups. VNO was similar at rest in the PPH patients (142±84 nL/min) and the normal subjects (117±45 nL/min), but lower in the PF patients (66±13 nL/min; p<0.05; analysis of variance with Bonferonni correction). While VNO in normal subjects more than doubled by peak exercise to 268±85 nL/min, there was no significant rise with exercise in either patient group (PPH, 155±81 nL/min; PF, 91±67 nL/min). Constant work rate exercise induced a significant rise in VNO in the normal subjects (rest, 101±68 nL/min; exercise, 147±87 nL/min; p<0.001) but no significant change in the PPH patients (rest, 127±111 nL/min; exercise, 68±65 nL/min).
Conclusions: We conclude that the low resting VNO in PF may be due to loss of normal functional pulmonary capillary bed. The increase in VNO seen in normal subjects may be associated with dilatation and recruitment of the pulmonary capillary bed during exercise, and failure to increase VNO during exercise in disease states may reflect an inability to recruit the capillary bed.
Submitted on April 24, 1996
This article has been cited by other articles:
|
|
 |
|
  R. E. Girgis, H. C. Champion, G. B. Diette, R. A. Johns, S. Permutt, and J. T. Sylvester Decreased Exhaled Nitric Oxide in Pulmonary Arterial Hypertension: Response to Bosentan Therapy Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 352 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005 Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 912 - 930. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vonk-Noordegraaf, S. A. van Wolferen, J. T. Marcus, A. Boonstra, P. E. Postmus, J. W. L. Peeters, and A. J. Peacock Noninvasive assessment and monitoring of the pulmonary circulation Eur. Respir. J., April 1, 2005; 25(4): 758 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. ElHalawani, N. T. Ly, R. T. Mahon, and D. E. Amundson Exhaled Nitric Oxide as a Predictor of Exercise-Induced Bronchoconstriction Chest, August 1, 2003; 124(2): 639 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.A. Barbera, V.I. Peinado, and S. Santos Pulmonary hypertension in chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2003; 21(5): 892 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mehta Sildenafil for Pulmonary Arterial Hypertension: Exciting, But Protection Required Chest, April 1, 2003; 123(4): 989 - 992. [Full Text] [PDF]
|
|
|
|
 |
|
 F L M Ricciardolo Multiple roles of nitric oxide in the airways Thorax, February 1, 2003; 58(2): 175 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B-;M. Sundblad, B-;M. Larsson, L. Palmberg, and K. Larsson Exhaled nitric oxide and bronchial responsiveness in healthy subjects exposed to organic dust Eur. Respir. J., August 1, 2002; 20(2): 426 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. DELCLAUX, B. MAHUT, F. ZERAH-LANCNER, C. DELACOURT, S. LAOUD, D. CHERQUI, C. DUVOUX, A. MALLAT, and A. HARF Increased Nitric Oxide Output from Alveolar Origin during Liver Cirrhosis versus Bronchial Source during Asthma Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 332 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Budts, P. Pokreisz, Z. Nong, N. Van Pelt, H. Gillijns, R. Gerard, R. Lyons, D. Collen, K. D. Bloch, and S. Janssens Aerosol Gene Transfer With Inducible Nitric Oxide Synthase Reduces Hypoxic Pulmonary Hypertension and Pulmonary Vascular Remodeling in Rats Circulation, December 5, 2000; 102(23): 2880 - 2885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Riley, J.a. Porszasz, M. P. K. J. Engelen, S. M. Shapiro, B. H. Brundage, and K. Wasserman Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide J. Am. Coll. Cardiol., August 1, 2000; 36(2): 547 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. CLINI, G. CREMONA, M. CAMPANA, C. SCOTTI, M. PAGANI, L. BIANCHI, A. GIORDANO, and N. AMBROSINO Production of Endogenous Nitric Oxide in Chronic Obstructive Pulmonary Disease and Patients with Cor Pulmonale . Correlates with Echo-Doppler Assessment Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 446 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hasuda, T. Satoh, A. Shimouchi, F. Sakamaki, S. Kyotani, T. Matsumoto, Y. Goto, and N. Nakanishi Improvement in Exercise Capacity With Nitric Oxide Inhalation in Patients With Precapillary Pulmonary Hypertension Circulation, May 2, 2000; 101(17): 2066 - 2070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Silkoff Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children---1999 . THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY WAS ADOPTED BY THE ATS BOARD OF DIRECTORS, JULY 1999 Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2104 - 2117. [Full Text]
|
|
|
|
 |
|
 A. P. Pietropaoli, I. B. Perillo, A. Torres, P. T. Perkins, L. M. Frasier, M. J. Utell, M. W. Frampton, and R. W. Hyde Simultaneous measurement of nitric oxide production by conducting and alveolar airways of humans J Appl Physiol, October 1, 1999; 87(4): 1532 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. ST. CROIX, T. J. WETTER, D. F. PEGELOW, K. C. MEYER, and J. A. DEMPSEY Assessment of Nitric Oxide Formation During Exercise Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1125 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Geigel, R. W. Hyde, I. B. Perillo, A. Torres, P. T. Perkins, A. P. Pietropaoli, L. M. Frasier, M. W. Frampton, and M. J. Utell Rate of nitric oxide production by lower alveolar airways of human lungs J Appl Physiol, January 1, 1999; 86(1): 211 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G Haworth Primary pulmonary hypertension in childhood Arch. Dis. Child., November 1, 1998; 79(5): 452 - 455. [Full Text]
|
|
|
|
|
|
S. L. ARCHER, K. DJABALLAH, M. HUMBERT, E. KENNETH WEIR, M. FARTOUKH, J. DALL'AVA-SANTUCCI, J.-C. MERCIER, G. SIMONNEAU, and A. TUAN DINH-XUAN Nitric Oxide Deficiency in Fenfluramine- and Dexfenfluramine-induced Pulmonary Hypertension Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1061 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. T. KANEKO, A. C. ARROLIGA, R. A. DWEIK, S. A. COMHAIR, D. LASKOWSKI, R. OPPEDISANO, M. J. THOMASSEN, and S. C. ERZURUM Biochemical Reaction Products of Nitric Oxide as Quantitative Markers of Primary Pulmonary Hypertension Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 917 - 923. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
